Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 24, 2019 16:15 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Strategic Transactions

Note Payment Received from Interpace Diagnostics Group, Inc. Settlement Agreement with NovellusDx Restructured Note Agreement with Unsecured Lender M&A Advisory Agreement with H.C....
October 24, 2019 08:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces 1-for-30 Reverse Stock Split

RUTHERFORD, N.J, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced that it...
May 06, 2019 09:20 ET | Source: Precipio, Inc.

Precipio Conducts IV-Cell™ Validation Trial with a Prominent Laboratory

NEW HAVEN, Conn., May 06, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it is in the process of completing a trial of its Proprietary IV-Cell...
November 02, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. is Among the First To Drive New FDA-Approved Testing Paradigm for Non-Small Cell Lung Cancer Patients by Offering Thermo Fisher Scientific’s Oncomine Dx Target Test

Thermo Fisher’s multi-biomarker test helps match lung cancer patients to FDA-approved therapies in days instead of weeksCGI and Thermo Fisher are collaborating with pharmaceutical partners and...
October 12, 2017 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. to Host Panel Discussion on “The Convergence of Artificial Intelligence and Healthcare - New Developments in Precision Medicine” During the 3rd Annual Dawson James Small Cap Growth Conference on October 18th

Cancer Genetics Will Also Present a Corporate Overview on Thursday, October 19th RUTHERFORD, N.J., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a...
December 14, 2016 11:36 ET | Source: American Health Council

American Health Council Names Carlos Encarnacion, M.D. to Physician Board

NEW YORK, Dec. 14, 2016 (GLOBE NEWSWIRE) -- Dr. Carlos Encarnacion, Physician at Texas Oncology, has been selected to join the Physician Board at the American Health Council. He will be sharing...